Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.
Ilander M, Olsson-Strömberg U, Schlums H, Guilhot J, Brück O, Lähteenmäki H, Kasanen T, Koskenvesa P, Söderlund S, Höglund M, Markevärn B, Själander A, Lotfi K, Dreimane A, Lübking A, Holm E, Björeman M, Lehmann S, Stenke L, Ohm L, Gedde-Dahl T, Majeed W, Ehrencrona H, Koskela S, Saussele S, Mahon FX, Porkka K, Hjorth-Hansen H, Bryceson YT, Richter J, Mustjoki S. Ilander M, et al. Leukemia. 2017 May;31(5):1108-1116. doi: 10.1038/leu.2016.360. Epub 2016 Nov 28. Leukemia. 2017. PMID: 27890936 Free PMC article. Clinical Trial.
Dasatinib Reversibly Disrupts Endothelial Vascular Integrity by Increasing Non-Muscle Myosin II Contractility in a ROCK-Dependent Manner.
Kreutzman A, Colom-Fernández B, Jiménez AM, Ilander M, Cuesta-Mateos C, Pérez-García Y, Arévalo CD, Brück O, Hakanen H, Saarela J, Ortega-Carrión A, de Rosendo A, Juanes-García A, Steegmann JL, Mustjoki S, Vicente-Manzanares M, Muñoz-Calleja C. Kreutzman A, et al. Among authors: ilander m. Clin Cancer Res. 2017 Nov 1;23(21):6697-6707. doi: 10.1158/1078-0432.CCR-16-0667. Epub 2017 Aug 18. Clin Cancer Res. 2017. PMID: 28821556
Immune control in chronic myeloid leukemia.
Ilander M, Mustjoki S. Ilander M, et al. Oncotarget. 2017 Nov 3;8(61):102763-102764. doi: 10.18632/oncotarget.22279. eCollection 2017 Nov 28. Oncotarget. 2017. PMID: 29262520 Free PMC article. No abstract available.
Immune cell phenotype and functional defects in Netherton syndrome.
Eränkö E, Ilander M, Tuomiranta M, Mäkitie A, Lassila T, Kreutzman A, Klemetti P, Mustjoki S, Hannula-Jouppi K, Ranki A. Eränkö E, et al. Among authors: ilander m. Orphanet J Rare Dis. 2018 Nov 26;13(1):213. doi: 10.1186/s13023-018-0956-6. Orphanet J Rare Dis. 2018. PMID: 30477583 Free PMC article.
27 results